Change of TIDM

March 15, 2019

Verseon Corporation

("Verseon" or the "Company")

Change of TIDM

FREMONT, Calif.-Verseon, a clinical-stage pharmaceutical company developing disruptive life-science technologies to advance global health, today announces that effective March 18, 2019, the Company's ticker symbol for the London Stock Exchange will change from 'VSN' to 'VERS'. The Company's ISIN and SEDOL will remain unchanged. 

About Verseon

Verseon Corporation is developing disruptive life-science technology to advance global health. The clinical-stage company is using its proprietary, computational drug discovery platform to discover new drug candidates that are unlikely to be found using conventional methods. Pairing its computational engines with a comprehensive in-house chemistry and biology workflow, the company has built a growing pipeline of drug programs. Verseon currently has four active drug programs in the areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology.

- Ends -

For further information, please contact:

For financial and business media enquiries, please contact

For trade and pharma media enquiries, please contact